Document is current
Any future updates will be listed below
-
Authors
- License Information
-
More Information
Article History
Received: 2 April 2025
Revised: 10 July 2025
Accepted: 20 July 2025
First Online: 2 August 2025
Declarations
:
: Not applicable.
: The authors declare no competing interests.
: AG received consultancy fees from Pfizer, Novartis, TissueGene, ICM, Medipost, and TrialSpark. He is a shareholder of Boston Imaging Core Lab., LLC. Andrew Kompel is a consultant/expert for Pacira, Caerus Medical.
